365 related articles for article (PubMed ID: 3488345)
21. Hyperthyroxinemic mice have reduced natural killer cell activity. Evidence for a defective trigger mechanism.
Stein-Streilein J; Zakarija M; Papic M; McKenzie JM
J Immunol; 1987 Oct; 139(7):2502-7. PubMed ID: 3498760
[TBL] [Abstract][Full Text] [Related]
22. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity.
Gersuk GM; Carmel R; Pattamakom S; Challita PM; Rabinowitz AP; Pattengale PK
Nat Immun; 1993; 12(3):136-51. PubMed ID: 8329837
[TBL] [Abstract][Full Text] [Related]
23. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
Roozemond RC; Bonavida B
J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
[TBL] [Abstract][Full Text] [Related]
24. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
25. Decreased natural cell-mediated cytotoxicity per effector cell in acquired immunodeficiency syndrome.
Baron GC; Klimas NG; Fischl MA; Fletcher MA
Diagn Immunol; 1985; 3(4):197-204. PubMed ID: 3866646
[TBL] [Abstract][Full Text] [Related]
26. Natural cytotoxic activity in a cloned natural killer cell line is mediated by tumor necrosis factor.
Richards AL; Dennert G; Pluznik DH; Takagaki Y; Djeu JY
Nat Immun Cell Growth Regul; 1989; 8(2):76-88. PubMed ID: 2761550
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
Nair MP; Schwartz SA
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of inhibition of human natural killer activity by ultraviolet radiation.
Weitzen ML; Bonavida B
J Immunol; 1984 Dec; 133(6):3128-32. PubMed ID: 6491282
[TBL] [Abstract][Full Text] [Related]
29. Natural killer cytotoxic factor induction by K562 cells in patients with advanced cancer: correlation with production of interferon.
Steinhauer EH; Doyle AT; Reed J; Kadish AS
J Natl Cancer Inst; 1985 Dec; 75(6):1017-23. PubMed ID: 2415742
[TBL] [Abstract][Full Text] [Related]
30. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
[TBL] [Abstract][Full Text] [Related]
31. The "lazy" NK cells of Chediak-Higashi syndrome.
Targan SR; Oseas R
J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
[TBL] [Abstract][Full Text] [Related]
32. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency syndrome patients in response to phytohemagglutinin or anti-CD16 monoclonal antibody.
Sirianni MC; Mezzaroma I; Aiuti F; Moretta A
Eur J Immunol; 1994 Aug; 24(8):1874-8. PubMed ID: 8056046
[TBL] [Abstract][Full Text] [Related]
33. Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells.
Bonavida B; Wright SC
J Clin Immunol; 1986 Jan; 6(1):1-8. PubMed ID: 3958135
[TBL] [Abstract][Full Text] [Related]
34. Effect of interleukin-12 on antitumor activity of human umbilical cord blood and bone marrow cytotoxic cells.
Condiotti R; Nagler A
Exp Hematol; 1998 Jul; 26(7):571-9. PubMed ID: 9657131
[TBL] [Abstract][Full Text] [Related]
35. Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
Roozemond RC; Urli DC; Wright SC; Graves SS; Bonavida B
Immunobiology; 1987 Dec; 176(1-2):35-46. PubMed ID: 3447981
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of interferon-alpha 2 and interleukin-2 on natural killer cell activity in patients with acquired immune deficiency syndrome.
Reddy MM; Chinoy P; Grieco MH
J Biol Response Mod; 1984 Aug; 3(4):379-86. PubMed ID: 6332880
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
Steele TA; Brahmi Z
J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
[TBL] [Abstract][Full Text] [Related]
39. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
40. Soluble cytotoxic factors and the mechanism of NK cell mediated cytotoxicity.
Bonavida B; Wright SC
Adv Exp Med Biol; 1982; 146():379-88. PubMed ID: 7102465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]